Skip to main content
main-content

01.12.2017 | Research | Sonderheft 3/2017 Open Access

BMC Medical Informatics and Decision Making 3/2017

Automatic schizophrenic discrimination on fNIRS by using complex brain network analysis and SVM

Zeitschrift:
BMC Medical Informatics and Decision Making > Sonderheft 3/2017
Autoren:
Hong Song, Lei Chen, RuiQi Gao, Iordachescu Ilie Mihaita Bogdan, Jian Yang, Shuliang Wang, Wentian Dong, Wenxiang Quan, Weimin Dang, Xin Yu

Abstract

Background

Schizophrenia is a kind of serious mental illness. Due to the lack of an objective physiological data supporting and a unified data analysis method, doctors can only rely on the subjective experience of the data to distinguish normal people and patients, which easily lead to misdiagnosis. In recent years, functional Near-Infrared Spectroscopy (fNIRS) has been widely used in clinical diagnosis, it can get the hemoglobin concentration through the variation of optical intensity.

Methods

Firstly, the prefrontal brain networks were constructed based on oxy-Hb signals from 52-channel fNIRS data of schizophrenia and healthy controls. Then, Complex Brain Network Analysis (CBNA) was used to extract features from the prefrontal brain networks. Finally, a classier based on Support Vector Machine (SVM) is designed and trained to discriminate schizophrenia from healthy controls. We recruited a sample which contains 34 healthy controls and 42 schizophrenia patients to do the one-back memory task. The hemoglobin response was measured in the prefrontal cortex during the task using a 52-channel fNIRS system.

Results

The experimental results indicate that the proposed method can achieve a satisfactory classification with the accuracy of 85.5%, 92.8% for schizophrenia samples and 76.5% for healthy controls. Also, our results suggested that fNIRS has the potential capacity to be an effective objective biomarker for the diagnosis of schizophrenia.

Conclusions

Our results suggested that, using the appropriate classification method, fNIRS has the potential capacity to be an effective objective biomarker for the diagnosis of schizophrenia.
Literatur
Über diesen Artikel

Weitere Artikel der Sonderheft 3/2017

BMC Medical Informatics and Decision Making 3/2017 Zur Ausgabe